Kronos Bio, Inc. Amortization of Debt Issuance Costs
Kronos Bio, Inc. reported Amortization of Debt Issuance Costs of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2022-02-24
- Kronos Bio, Inc. amortization of debt issuance costs for the quarter ending 2021-12-31 was $0.00.
- Kronos Bio, Inc. amortization of debt issuance costs for the quarter ending 2020-12-31 was $0.00.
- Kronos Bio, Inc. amortization of debt issuance costs for the quarter ending 2019-12-31 was $0.00.
- Kronos Bio, Inc. amortization of debt issuance costs for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Kronos Bio, Inc. amortization of debt issuance costs for fiscal 2020 was $3.89M.
- Kronos Bio, Inc. amortization of debt issuance costs for fiscal 2019 was $0.00.
- Kronos Bio, Inc. amortization of debt issuance costs for fiscal 2018 was $0.00.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $3.89M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $3.89M 10-Q · filed 2021-11-09 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-18 | ||
| 2018-12-31 | $0.00 10-K · filed 2021-03-23 |